Location History:
- Ely, GB (1996 - 1998)
- Cambs, GB (1999 - 2000)
- Huntingdon, GB (1991 - 2003)
Company Filing History:
4 out of 27 
4 out of 320 
3 out of 328 
Years Active: 1991-2003
Title: Innovator in Veterinary Vaccines: The Patents of Matthew M Binns
Introduction: Matthew M Binns is a prominent inventor based in Huntingdon, GB, known for his significant contributions to veterinary medicine through his extensive research in viral nucleotide sequences. With a total of 16 patents to his name, Binns has played a crucial role in developing innovations that enhance vaccine efficacy against various poultry viruses.
Latest Patents: Matthew M Binns' latest patents focus on viral nucleotide sequences related to significant poultry viruses, including the herpes virus of turkeys (HVT), Marek's disease virus (MDV), and infectious laryngotracheitis virus (ILTV). These patents identify non-essential regions and antigen-encoding sequences, contributing to the development of vaccines that utilize attenuated viruses or viruses carrying heterologous antigen-encoding sequences. The identified regions include key homologues of the herpes simplex virus (HSV) genes such as gC, gB, and gH, as well as essential genes for viral replication, providing critical insights for vaccine enhancement.
Career Highlights: Throughout his career, Binns has partnered with leading companies in the veterinary field, including Rhone Merieux and Merial Limited. His work has focused on advancing the understanding of viral genetics, paving the way for innovative vaccine solutions that respond to the challenges posed by poultry diseases.
Collaborations: Binns has collaborated with esteemed colleagues such as Louis Joseph Ross and Michael E Boursnell. This teamwork underscores the importance of collaboration in scientific research, fostering an environment where groundbreaking innovations can flourish.
Conclusion: Matthew M Binns stands out as a dedicated inventor in the realm of veterinary vaccines. His 16 patents reflect his commitment to improving animal health through scientific innovation. By manipulating viral nucleotide sequences, Binns is not only advancing vaccine technology but also contributing to the overall well-being of poultry and the agricultural economy.